TrialHead & neck2023

Neutrophil to lymphocyte ratio and peripheral blood biomarkers correlate with survival outcomes but not response among head and neck and salivary cancer treated with pembrolizumab and vorinostat.

Cassie Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.